# CINQAIR

NDC: 59310-610
Generic name: Reslizumab
Labeler / Manufacturer: Teva Respiratory, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20160418

FDA application: BLA761033

## Active ingredients

- RESLIZUMAB: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59310-610"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59310-610
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=053b9158-2a5b-48b9-bf47-5fa78a35ec33